Liver Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You must be 18 years of age or older
- You have been diagnosed with liver cancer (hepatocellular carcinoma) confirmed by a special type of CT scan or MRI scan showing specific patterns of blood flow in the liver
- You have been diagnosed with liver cancer confirmed by a tissue biopsy (if the scan results were not clear enough to make a diagnosis)
- You are scheduled to have surgery to remove part of your liver, or a procedure that uses heat to destroy the tumor (radiofrequency ablation)
- Your treatment plan has been reviewed and approved by a specialist cancer team
- You have read and understood the information provided about the trial and signed a form agreeing to take part
- You are receiving follow-up care at Charles Nicolle University Hospital in Rouen
Who may not be able to join:
- You currently have another type of active cancer or a blood cancer
- You have a medical reason that means surgery is not safe for you
- You are not registered with the French social security system
- You are currently pregnant, have recently given birth, or are breastfeeding
- You are under any form of legal protection or guardianship (such as a court-appointed guardian or legal representative managing your affairs)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Edouard ROUSSEL, MD, University Hospital, Rouen
Phone: +3323288
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in tcNA dosage between baseline and 6 Months; Change in tcDNA dosage between baseline and 3 Months
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.